P2a Open Label Study to Evaluate 2-HPβCD in Subjects With Diabetic Kidney Disease
Clinical trial NCT06489340 · WITHDRAWN
Trial details
- NCT number
- NCT06489340
- Sponsor
- ZyVersa Therapeutics, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-11
- Primary completion
- 2026-08-11
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.